Cytomegalic Inclusion Disease Overview
Learn About Cytomegalic Inclusion Disease
Mark Schleiss is a Pediatrics specialist and an Infectious Disease provider in Minneapolis, Minnesota. Dr. Schleiss is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. His top areas of expertise are Congenital Cytomegalovirus, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Sepsis, and Myringotomy. Dr. Schleiss is currently accepting new patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.
Michael Boeckh is an Infectious Disease provider in Seattle, Washington. Dr. Boeckh is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Parainfluenza, and Shingles. Dr. Boeckh is currently accepting new patients.
Summary: This phase III trial determines whether taking prophylactic letermovir will reduce the likelihood of infection with cytomegalovirus (CMV) in children and adolescents after stem cell transplant. The treatments used to prepare for HCT reduce the body's natural infection-fighting ability and increase the likelihood of an infection with a virus called cytomegalovirus. Prophylaxis means to take a drug ...
Summary: This is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled. Group 1 will be comprised of 4 subjects. Following documentation study inclusion and signing of informed consent, Group 1 subjects will receive one dose of oral letermovir (Study Day 0), using the dose bands. A full pharmacokinetics (...


